Boundless Bio, Inc. BOLD
Set alert
At close · Oct 30
After hours · Oct 30, 4:00 PM ET
- YTD
- +105.83%
- 1 year
- +78.99%
- Open
- 2.53
- Prev close
- 2.48
- Mkt cap
- 57.08M
- Vol
- 47.01K
- Avg vol
- 179.01K
- EPS
- -2.85
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 2.43
- High
- 2.59
- Forward P/E
- -0.70
- Beta
- 0.00
- Short ratio
- 2.01
- Inst. own
- 75.86%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Feb 6, 2025
- 50-d avg
- 2.91
- 200-d avg
- 5.46
- 1y target
- 14.50
5D chart
Signals (68)
| Name | Time | Ago |
|---|---|---|
| MACD: Buy Signal | Oct 30, 1:35 PM | 1 day ago |
| MACD: Sell Signal | Oct 30, 12:25 PM | 1 day ago |
| SMA: Bearish | Oct 30, 12:20 PM | 1 day ago |
| SMA: Bullish | Oct 30, 11:35 AM | 1 day ago |
| MACD: Buy Signal | Oct 30, 11:25 AM | 1 day ago |
| SMA: Bearish | Oct 30, 10:55 AM | 1 day ago |
| MACD: Sell Signal | Oct 30, 10:05 AM | 1 day ago |
| SMA: Bearish | Oct 30, 9:50 AM | 1 day ago |
| RSI: Overbought | Oct 30, 9:45 AM | 1 day ago |
| MACD: Buy Signal | Oct 29, 2:40 PM | 2 days ago |
| MACD: Sell Signal | Oct 29, 2:35 PM | 2 days ago |
| MACD: Buy Signal | Oct 29, 2:15 PM | 2 days ago |
| MACD: Sell Signal | Oct 29, 1:50 PM | 2 days ago |
| RSI: Oversold | Oct 29, 1:50 PM | 2 days ago |
| MACD: Buy Signal | Oct 29, 1:45 PM | 2 days ago |
| RSI: Oversold | Oct 29, 1:10 PM | 2 days ago |
| RSI: Oversold | Oct 29, 12:45 PM | 2 days ago |
| MACD: Sell Signal | Oct 29, 11:00 AM | 2 days ago |
| SMA: Bearish | Oct 29, 10:55 AM | 2 days ago |
| SMA: Bullish | Oct 29, 10:40 AM | 2 days ago |
| MACD: Buy Signal | Oct 29, 10:40 AM | 2 days ago |
| MACD: Sell Signal | Oct 29, 10:25 AM | 2 days ago |
| SMA: Bullish | Oct 29, 9:30 AM | 2 days ago |
| MACD: Buy Signal | Oct 29, 9:30 AM | 2 days ago |
| SMA: Bearish | Oct 28, 3:55 PM | 3 days ago |
| SMA: Bullish | Oct 28, 3:40 PM | 3 days ago |
| SMA: Bearish | Oct 28, 2:55 PM | 3 days ago |
| SMA: Bearish | Oct 28, 2:40 PM | 3 days ago |
| SMA: Bullish | Oct 28, 2:35 PM | 3 days ago |
| SMA: Bearish | Oct 28, 2:30 PM | 3 days ago |
| SMA: Bullish | Oct 28, 2:15 PM | 3 days ago |
| MACD: Sell Signal | Oct 28, 2:05 PM | 3 days ago |
| MACD: Buy Signal | Oct 28, 1:45 PM | 3 days ago |
| SMA: Bullish | Oct 28, 1:40 PM | 3 days ago |
| MACD: Sell Signal | Oct 28, 1:15 PM | 3 days ago |
| MACD: Buy Signal | Oct 28, 12:50 PM | 3 days ago |
| RSI: Overbought | Oct 28, 12:50 PM | 3 days ago |
| MACD: Sell Signal | Oct 28, 12:45 PM | 3 days ago |
| SMA: Bullish | Oct 28, 12:05 PM | 3 days ago |
| SMA: Bearish | Oct 28, 12:00 PM | 3 days ago |
| RSI: Overbought | Oct 28, 11:45 AM | 3 days ago |
| SMA: Bullish | Oct 28, 11:35 AM | 3 days ago |
| MACD: Buy Signal | Oct 28, 11:35 AM | 3 days ago |
| MACD: Sell Signal | Oct 28, 11:25 AM | 3 days ago |
| SMA: Bearish | Oct 28, 11:20 AM | 3 days ago |
| SMA: Bullish | Oct 28, 11:10 AM | 3 days ago |
| SMA: Bearish | Oct 28, 11:05 AM | 3 days ago |
| MACD: Buy Signal | Oct 28, 10:40 AM | 3 days ago |
| RSI: Overbought | Oct 28, 10:40 AM | 3 days ago |
| MACD: Sell Signal | Oct 27, 3:45 PM | 4 days ago |
| MACD: Buy Signal | Oct 27, 3:25 PM | 4 days ago |
| MACD: Sell Signal | Oct 27, 2:55 PM | 4 days ago |
| RSI: Overbought | Oct 27, 2:15 PM | 4 days ago |
| MACD: Buy Signal | Oct 27, 1:50 PM | 4 days ago |
| MACD: Sell Signal | Oct 27, 1:35 PM | 4 days ago |
| MACD: Buy Signal | Oct 27, 1:10 PM | 4 days ago |
| MACD: Sell Signal | Oct 27, 12:45 PM | 4 days ago |
| MACD: Buy Signal | Oct 27, 12:05 PM | 4 days ago |
| MACD: Sell Signal | Oct 27, 10:30 AM | 4 days ago |
| RSI: Overbought | Oct 27, 9:30 AM | 4 days ago |
| MACD: Buy Signal | Oct 26, 3:45 PM | 5 days ago |
| MACD: Sell Signal | Oct 26, 2:50 PM | 5 days ago |
| MACD: Buy Signal | Oct 26, 2:40 PM | 5 days ago |
| MACD: Sell Signal | Oct 26, 2:35 PM | 5 days ago |
| SMA: Bullish | Oct 26, 11:15 AM | 5 days ago |
| SMA: Bearish | Oct 26, 11:10 AM | 5 days ago |
| SMA: Bullish | Oct 26, 11:05 AM | 5 days ago |
| SMA: Bearish | Oct 26, 10:20 AM | 5 days ago |
News
2 weeks ago gurufocus.com
Are OPCH, PCRX, RXO, BOLD Obtaining Fair Deals for their Shareholders?
Are OPCH, PCRX, RXO, BOLD Obtaining Fair Deals for their Shareholders?PR NewswireNEW YORK, Oct. 12, 2026Insiders may stand to receive substantial financial bene
2 weeks ago prnewswire.com
Are OPCH, PCRX, RXO, BOLD Obtaining Fair Deals for their Shareholders?
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws
1 month ago globenewswire.com
Serapha Bio Appoints Kenneth T. Mills as Chief Executive Officer and Names Senior Leadership Team to Advance Potential Best-in-Class in vivo Base Editing Program for Alpha-1 Antitrypsin Deficiency
- Daphne Karydas appointed as President and Chief Financial Officer - Weston Miller, MD, appointed as Chief Medical Officer - Additional appointments: Nina Hunter, PhD, as Chief Development Officer…
-
1 month ago benzinga.com
Callio Therapeutics Appoints Zachary Hornby As CEO
Veteran biotech executive to lead company growth as it advances multiple dual-payload ADCs through clinical development for people living with cancerPiers Ingram, PhD, Co-Founder, transitions to…
1 month ago globenewswire.com
Callio Therapeutics Appoints Zachary Hornby as Chief Executive Officer
Veteran biotech executive to lead company growth as it advances multiple dual-payload ADCs through clinical development for people living with cancer Piers Ingram, PhD, Co-Founder, transitions to…
-
2 months ago benzinga.com
Boundless Bio Q2 EPS $(1.06) Misses $(0.61) Estimate
Boundless Bio (NASDAQ:BOLD) reported quarterly losses of $(1.06) per share which missed the analyst consensus estimate of $(0.61) by 73.77 percent. This is a 51.43 percent decrease over losses of…
4 months ago globenewswire.com
Halper Sadeh LLC is Investigating Whether BOLD and NDRA are Obtaining Fair Deals for their Shareholders
Insiders may stand to receive substantial financial benefits not available to ordinary shareholders.
4 months ago gurufocus.com
Are TECH, APGE, BOLD, REFI Obtaining Fair Deals for their Shareholders?
Are TECH, APGE, BOLD, REFI Obtaining Fair Deals for their Shareholders? PR Newswire NEW YORK, June 25, 2026
4 months ago gurufocus.com
$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Boundless Bio, Inc. (NASDAQ: BOLD)
$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Boundless Bio, Inc. (NASDAQ: BOLD) PR Newswire
4 months ago prnewswire.com
$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Boundless Bio, Inc. (NASDAQ: BOLD)
NEW YORK, June 23, 2026 /PRNewswire/ -- Class Action Attorney Juan Monteverde with Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered millions of dollars for shareholders and is…
4 months ago benzinga.com
12 Health Care Stocks Moving In Tuesday's Intraday Session
Gainers Aditxt (NASDAQ:ADTX) shares increased by 151.6% to $0.05 during Tuesday's regular session. Atlantic International (NASDAQ:ATLN) stock rose 143.31% to $1.07. The market value of their…
4 months ago benzinga.com
Crude Oil Down Over 1%; US Manufacturing PMI Surges In June
US stocks lower, Nasdaq falls 500 points. Dow down 0.04%, Nasdaq 1.91%, S&P 500 1.27%. Consumer staples up 1.4%, tech down 2.3%. S&P PMI rises.
4 months ago businesswire.com
BOLD Stock Alert: Halper Sadeh LLC is Investigating Whether Boundless Bio, Inc. is Obtaining a Fair Price for its Shareholders
NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating the merger of Boundless Bio, Inc. (NASDAQ: BOLD) and Serapha Bio, Inc. Upon closing of the proposed…
4 months ago benzinga.com
Dow Falls Over 300 Points; Korn Ferry Earnings Top Views
US stocks down as Dow falls 300 points, while S&P 500 and NASDAQ also decrease. Consumer staples rise, tech stocks fall. Korn Ferry beats earnings.
4 months ago benzinga.com
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Gainers HeartSciences (NASDAQ:HSCS) stock rose 82.2% to $3.23 during Tuesday's pre-market session. The company's market cap stands at $5.6 million. Boundless Bio (NASDAQ:BOLD) shares rose 62.85% to…
-
4 months ago benzinga.com
Boundless Bio, Serapha Bio Ink All-Stock Merger Agreement; Combined Entity Anticipated To Trade On Nasdaq Under AATD Symbol
Boundless Bio, Inc. (Nasdaq: BOLD) and Serapha Bio, Inc., a privately held biotechnology company developing an investigational in vivo base editing therapy for Alpha-1 Antitrypsin Deficiency (AATD),…
4 months ago globenewswire.com
Boundless Bio and Serapha Bio Announce Merger Agreement and $230 Million Concurrent Private Placement
Combined company to operate as Serapha Bio and to advance Serapha's potential best-in-class in vivo base editing program for Alpha-1 Antitrypsin Deficiency
-
5 months ago benzinga.com
Boundless Bio Q1 EPS $(0.60) Beats $(0.64) Estimate
Boundless Bio (NASDAQ:BOLD) reported quarterly losses of $(0.60) per share which beat the analyst consensus estimate of $(0.64) by 4.76 percent. This is a 15.49 percent increase over losses of…
5 months ago globenewswire.com
Boundless Bio Reports First Quarter 2026 Financial Results and Business Highlights
Enrollment proceeding in KOMODO-1 first-in-human clinical trial of BBI-940 $93 million in cash provides runway through expected clinical proof-of-concept readout for KOMODO-1 SAN DIEGO, May 08, 2026…
-
6 months ago benzinga.com
Boundless Bio Reveals Preclinical Breast Cancer Data from its Oral Kinesin Degrader Program at 2026 AACR Annual Meeting
Boundless Bio (NASDAQ:BOLD), a clinical-stage oncology company interrogating extrachromosomal DNA (ecDNA) biology to deliver transformative therapies to patients with previously intractable oncogene…
6 months ago globenewswire.com
Boundless Bio Presents Preclinical Breast Cancer Data from its Oral Kinesin Degrader Program at 2026 AACR Annual Meeting
Findings support the ongoing Phase 1 clinical development of BBI-940, an oral, selective kinesin degrader, as a potential first-in-class therapy for select advanced or metastatic breast cancers…
-
6 months ago benzinga.com
12 Health Care Stocks Moving In Tuesday's Intraday Session
12 Health Care Stocks Moving In Tuesday's Intraday Session
6 months ago benzinga.com
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
7 months ago globenewswire.com
NurExone Receives First Place in Healthcare at BOLD Awards VII and Engages Investor Brand Network to Support Awareness Strategy
TORONTO and HAIFA, Israel, April 01, 2026 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (FSE: J90) (“NurExone” or the “Company”), a biotechnology company developing…
7 months ago seekingalpha.com
Boundless Bio: An Underestimated Biotech With A First-In-Class EcDNA Targeted Kinesin Degrader
Boundless Bio offers a highly asymmetric risk/reward profile, trading at a $25M valuation with $107.6M in cash and a runway into 2H 2028. BBI-940, BOLD's first direct ecDNA-targeting asset, is…
-
7 months ago benzinga.com
Boundless Bio To Present Oral Kinesin Degrader Program At The AACR Annual Meeting 2026
Boundless Bio (NASDAQ:BOLD), a clinical-stage oncology company interrogating extrachromosomal DNA (ecDNA) biology to deliver transformative therapies to patients with previously intractable oncogene…
7 months ago globenewswire.com
Boundless Bio Announces Upcoming Presentation of Oral Kinesin Degrader Program at the American Association for Cancer Research Annual Meeting 2026
SAN DIEGO, March 17, 2026 (GLOBE NEWSWIRE) -- Boundless Bio (Nasdaq: BOLD), a clinical-stage oncology company interrogating extrachromosomal DNA (ecDNA) biology to deliver transformative therapies to…
7 months ago globenewswire.com
NurExone Announces Corporate Updates
Consulting Agreement with Former Bayer Principal Scientist, BOLD Awards Healthcare Finalist Status, and Private Placement Closing Consulting Agreement with Former Bayer Principal Scientist, BOLD…
7 months ago prnewswire.com
DOT'S® INTRODUCES DOT'S ORIGINAL SNACK MIX - A BOLD NEW TAKE ON SNACKING
Dot's brings its iconic buttery-rich pretzels and bold Original seasoning to Snack Mix! HERSHEY, Pa.
-
7 months ago benzinga.com
Boundless Bio Q4 EPS $(0.58) Misses $(0.52) Estimate
Boundless Bio (NASDAQ:BOLD) reported quarterly losses of $(0.58) per share which missed the analyst consensus estimate of $(0.52) by 11.54 percent. This is a 21.62 percent increase over losses of…
7 months ago globenewswire.com
Boundless Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Business Highlights
KOMODO-1 first-in-human clinical trial of BBI-940 open for enrollment $108 million in cash provides runway into the second half of 2028, through expected clinical proof-of-concept readout for…
8 months ago globenewswire.com
Boundless Bio to Participate in the Leerink Global Healthcare Conference
SAN DIEGO, March 04, 2026 (GLOBE NEWSWIRE) -- Boundless Bio (Nasdaq: BOLD), a clinical-stage oncology company interrogating extrachromosomal DNA (ecDNA) biology to deliver transformative therapies to…
8 months ago zacks.com
Boundless Bio, Inc. (BOLD) Upgraded to Buy: Here's Why
Boundless Bio, Inc. (BOLD) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
8 months ago benzinga.com
12 Health Care Stocks Moving In Monday's Pre-Market Session
12 Health Care Stocks Moving In Monday's Pre-Market Session
-
9 months ago benzinga.com
The FDA Accepts Boundless Bio's Investigational New Drug Application for BBI-940; Also, the Company Will Cease Enrollment in Phase 1/2 POTENTIATE Trial of BBI-355 Combined With BBI-825 in Oncogene-amplified Cancers
BBI-940 novel Kinesin degrader programThe acceptance of the BBI-940 IND enables Boundless to advance the program into a first-in-human clinical trial for patients with metastatic breast cancer,…
-
6 years ago benzinga.com
Stocks That Hit 52-Week Highs On Friday
Stocks That Hit 52-Week Highs On Friday
-
6 years ago benzinga.com
Stocks That Hit 52-Week Highs On Wednesday
Stocks That Hit 52-Week Highs On Wednesday
-
6 years ago benzinga.com
Stocks That Hit 52-Week Highs On Tuesday
Stocks That Hit 52-Week Highs On Tuesday
-
7 years ago benzinga.com
Benzinga's Top Upgrades, Downgrades For October 3, 2019
Benzinga's Top Upgrades, Downgrades For October 3, 2019
-
7 years ago benzinga.com
Stocks Which Set New 52-Week Low Yesterday, Wed., Nov. 7, 2018
Stocks Which Set New 52-Week Low Yesterday, Wed., Nov. 7, 2018
-
7 years ago benzinga.com
70 Stocks Moving In Wednesday's Mid-Day Session
70 Stocks Moving In Wednesday's Mid-Day Session